Related Experiment Video
Updated: Oct 25, 2025

07:49
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
Published on: May 30, 2025
1.7K
Augmenting and directing long-range CRISPR-mediated activation in human cells.
Y Esther Tak1,2,3,4, Joy E Horng1,2,3, Nicholas T Perry1,2,3
1Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA, USA.
Nature Methods
|August 6, 2021
Summary
Epigenetic editing using artificial transcription factors (aTFs) can be enhanced. Targeting aTFs to both promoters and enhancers improves gene activation efficiency and reliability for research and therapeutics.
Area of Science:
- Molecular Biology
- Gene Regulation
- Epigenetics
Background:
- Epigenetic editing employs artificial transcription factors (aTFs) to modulate gene expression.
- While targeting aTFs to promoters robustly upregulates human genes, activation via distal enhancers is less consistent.
- aTFs offer a powerful tool for precise gene regulation.
Purpose of the Study:
- To enhance the efficiency and reliability of long-range gene activation using CRISPR-based aTFs directed at distal enhancers.
- To demonstrate the utility of this enhanced strategy for controlling gene expression from specific enhancers and achieving allele-selective gene activation.
Main Methods:
- CRISPR-based artificial transcription factors (aTFs) were employed for epigenetic editing.
- The strategy involved concurrently targeting aTFs to both the target gene promoter and distal enhancers.
- Single-nucleotide polymorphisms (SNPs) within distal sequences were utilized for allele-specific targeting.
Main Results:
- Concurrent targeting of aTFs to promoters and enhancers significantly improved the efficiency and reliability of long-range gene activation in human cells.
- The approach enabled precise targeting of gene expression from enhancers capable of regulating multiple promoters.
- Allele-selective gene activation was achieved by targeting aTFs to SNPs in distal regulatory elements.
Conclusions:
- Combining promoter and enhancer targeting with aTFs represents a significant advancement in epigenetic editing.
- This refined strategy expands the capabilities of the epigenetic editing toolbox for diverse research applications.
- The enhanced method holds promise for developing novel therapeutic strategies involving precise gene regulation.
Related Concept Videos
CRISPR/Cas9 Genome Editing
716
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
716
CRISPR
53.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.6K
Homologous Recombination
56.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
56.6K

